Next Article in Journal
Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges
Next Article in Special Issue
In Vitro Assessment of Clevidipine Using the Profilin1 Hypertensive Mouse Model
Previous Article in Journal
A Potent (R)-alpha-bis-lipoyl Derivative Containing 8-Hydroxyquinoline Scaffold: Synthesis and Biological Evaluation of Its Neuroprotective Capabilities in SH-SY5Y Human Neuroblastoma Cells
Open AccessReview

Clevidipine for Perioperative Blood Pressure Control in Infants and Children

Departments of Anesthesiology & Pain Medicine, Nationwide Children's Hospital and The Ohio State University, 700 Children's Drive Columbus, OH 43205, USA
Departments of Anesthesiology and Neurological Surgery, Wexner Medical Center, The Ohio State University, 410 W 10th Ave Columbus, OH 43210, USA
Author to whom correspondence should be addressed.
Pharmaceuticals 2013, 6(1), 70-84;
Received: 11 December 2012 / Revised: 28 December 2012 / Accepted: 11 January 2013 / Published: 15 January 2013
(This article belongs to the Special Issue Calcium Antagonists)
Various pharmacologic agents have been used for perioperative BP control in pediatric patients, including sodium nitroprusside, nitroglycerin, β-adrenergic antagonists, fenoldopam, and calcium channel antagonists. Of the calcium antagonists, the majority of the clinical experience remains with the dihydropyridine nicardipine. Clevidipine is a short-acting, intravenous calcium channel antagonist of the dihydropyridine class. It undergoes rapid metabolism by non-specific blood and tissue esterases with a half-life of less than 1 minute. As a dihydropyridine, its cellular and end-organ effects parallel those of nicardipine. The clevidipine trials in the adult population have demonstrated efficacy in rapidly controlling BP in various clinical scenarios with a favorable adverse effect profile similar to nicardipine. Data from large clinical trials regarding the safety and efficacy of clevidipine in children is lacking. This manuscript aims to review the commonly used pharmacologic agents for perioperative BP control in children, discuss the role of calcium channel antagonists such as nicardipine, and outline the preliminary data regarding clevidipine in the pediatric population. View Full-Text
Keywords: clevidipine; pediatric hypertension; acute hypertension clevidipine; pediatric hypertension; acute hypertension
MDPI and ACS Style

Tobias, J.D.; Tulman, D.B.; Bergese, S.D. Clevidipine for Perioperative Blood Pressure Control in Infants and Children. Pharmaceuticals 2013, 6, 70-84.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop